Calcium Channel Blocking Drugs.

Slides:



Advertisements
Similar presentations
C ALCIUM C HANNEL B LOCKERS (CCB) Maureen McGuinness, RN (Karch, 2013)
Advertisements

Calcium Channel Blocking Drugs. Chemical TypeChemical NamesBrand Names PhenylalkylaminesverapamilCalan, Calna SR, Isoptin SR, Verelan BenzothiazepinesdiltiazemCardizem.
MEDPHARM DRUGS FOR ISCHEMIC HEART DISEASE FEBRUARY 10,2110.
Antiarrhythmic Agents: Cardiac Stimulants and Depressants
Drugs to treat angina. I. Introduction Branching off the aorta are the coronary arteries.
B) Drug Therapy (Antihypertensives) ACEi B.B CCB D iuretics. Centrally acting agents: alphametyldopa, HTN + pregnancy.
Pharmacology I Drugs Used to Treat Arrhythmias. Arrhythmias Needing Treatment: Atrial Fibrillation/Flutter (AF) Supraventricular Tachycardia (SVT) Ventricular.
Calcium antagonists (Summary) Dr Ivan Lambev
Clinical Toxicology & Pharmacology, Newcastle Mater Misericordiae Hospital Calcium channel blockers Professor Ian Whyte Hunter Area Toxicology Service.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 45 Calcium Channel Blockers.
Calcium Channel Blocking Drugs.
Angina Pectoris “Chest pain” or angina pectoris is a symptom of ischemic heart disease caused by an imbalance between oxygen requirement of the heart and.
Calcium Antagonists Tatyana Voyno-Yasenetskaya
Chapter 18 Agents that Dilate Blood Vessels. Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved Coronary.
1 COMMON USED CARDIAC MEDICATIONS By: Lisa Nie RN, MSN, CMSRN Clinical Nurse Specialist in Cardiology.
Cardio pharmacology Angina. angina Causes Atheroma Others: Aortic stenosis, aberrant coronary circulation, severe anaemia, arteritis Prevention Decrease.
 Prepared by:  Dr Rasol M Hasan. Anti- HYPERTENSIVE Drugs.
Drugs in the Therapy of Angina Dr. Thomas Abraham PHAR417: Fall 2004.
Head Lines Etiology Risk factors Mechanism Complications Treatment.
Drug Therapy Heart Failure by Pat Woodbery, MSN, ARNP.
OBJECTIVES At the end of lectures the students should Describe the different classes of drugs used for treatment of acute & chronic heart failure.
Excitable tissue- cardiac muscle Dr. Shafali Singh.
Drugs for Congestive Heart Failure
Amlodipine -Calcium Channel Blocker-
Calcium Channel Blockers and Digitalis. Dig Ca Channel Blockers.
Agents that Dilate Coronary Blood Vessels.  Coronary artery disease (CAD) results from atherosclerosis  Clinical symptoms caused by  narrowing of the.
Antianginal Drugs Learning outcomes Recognize variables contributing to a balanced myocardial supply versus demand Expand on the drugs used to alleviate.
for more lecture notes Antianginal Agents Dr.Shadi-Sarahroodi Pharm.D & PhD Qom University of Medical sciences Iran PUBLISHED.
They bind to the channel from the inner side of the membrane. They bind to channels in depolarized membranes. Binding  ↓ frequency of opening of the channels.
Antianginal Drugs Dr. Dennis Wolff Dept. Pharmacology, ext
Antianginal drugs Angina pectoris is the severe chest pain that occurs when coronary blood flow is inadequate to supply the oxygen required by the heart.
Prepared By MARIAM SALEH ALAMRO A Calcium Channel Blocker.
Angina pectoris Sudden,severe,pressing chest pain starting substernal &radiate to left arm. Due to imbalance between myocardium oxygen requirement and.
Calcium. Role of Ca ++ in Cardiac and Smooth Muscle  Changes in intracellular Ca ++ regulate contraction through different mechanisms in cardiac and.
Drugs used in angina pectoris
Angina pectoris Sudden, severe, pressing chest pain and radiating to the neck, jaw, back, and arms. The episodes are transient, stay between 15 sec to.
- Calcium channel blockers decrease blood pressure,cardiac workload, and myocardial oxygen consumption. - available in immediate-release and sustained-release.
Section III Circulation system.
Antianginal drugs Antidysrrhytmic drugs
Angina pectoris Sudden,severe,pressing chest pain starting substernal &radiate to left arm & neck. Due to imbalance between myocardium oxygen requirement.
Calcium Channel Blockers. Smooth muscle: Most types of smooth muscle are dependent on transmembrane calcium influx for normal resting tone.
CCB in Management of Hypertension in Older Persons Presented by Mona Ahmed sherif Marwa Shaaban Shimaa Adel Ahmed Salma Sadek Alia khalid.
Calcium antagonists (Summary) Dr Ivan Lambev
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc.1 Drugs for Angina Pectoris.
1 Copyright © 2012, 2009, 2006, 2003 by Saunders, an imprint of Elsevier Inc. Chapter 42 CARDIAC GLYCOSIDES, ANTIANGINALS, AND ANTIDYSRHYTHMICS.
Drugs acting on circulation system and blood / blood- forming organs.
PHARMACOLOGY OF ANTI-ANGINAL DRUGS (ID#580) Dr. Mariam Yousif Pharmacology & Toxicology Dept. November 17 th, 2014.
Anti- anginal drugs.
Drug Therapy of Angina Pectoris
CREATED BY Prof. Azza El-Medany
Prof. Abdulrahman Al-Motrefi
Antihypertensive Agents
Drugs Affecting the Cardiovascular System
Anti-Anginal Drugs.
Treatment of Congestive Heart Failure
Anti-Anginal Agents Angina Disease, symptoms
Drug Therapy Heart Failure
The Cardiovascular System
CALCIUM CHANNEL BLOCKERS/ANTAGONISTS
Anti Anginal Agents Pharmacology Week 10.
Anti-Anginal Drugs.
ACUTE SELF-POISONINGS BY VERAPAMIL
ANTI HYPERTENSIVE DRUGS
CALCIUM CHANNEL BLOCKERS/ANTAGONISTS
Antianginal Drugs.
Anti hypertensive Drugs
CARDIOVASCULAR AGENTS
Antianginal Drugs Ass. Prof. Naza M. Ali Lec 3-4 G2 21 April 2019
Anti Anginal Agents Pharmacology Week 10.
Drugs used in the treatment of Hypertension I
Presentation transcript:

Calcium Channel Blocking Drugs

Outline Introduction Pharmacokinetics CCB binding sites Heterogeneity of action Cardiac & hemodynamic differentiation Pharmacokinetics Adverse effects Contraindications Summary

Three Classes of CCBs Chemical Type Chemical Names Brand Names Phenylalkylamines verapamil Calan, Calna SR, Isoptin SR, Verelan Benzothiazepines diltiazem Cardizem CD, Dilacor XR 1,4-Dihydropyridines Nifedipine   nicardipine isradipine felodipine amlodipine Adalat CC, Procardia XL Cardene DynaCirc Plendil Norvasc

Widespread use of CCBs Angina pectoris Hypertension Treatment of supraventricular arrhythmias - Atrial Flutter - Atrial Fibrillation - Paroxysmal SVT

Outline Introduction Pharmacokinetics CCB binding sites Heterogeneity of action Cardiac & hemodynamic differentiation Pharmacokinetics Adverse effects Contraindications Summary

The Three Classes of CCBs Bind to Different Sites 1,4- Dihydropyridines (nifedipine) Phenylalkylamines (verapamil) Benzothiazepines (diltiazem) Ca2+ pore - +

CCBs – Mechanisms of Action Increase the time that Ca2+ channels are closed Relaxation of the arterial smooth muscle but not much effect on venous smooth muscle Significant reduction in afterload but not preload

Outline Introduction Pharmacokinetics CCB binding sites Heterogeneity of action Cardiac & hemodynamic differentiation Pharmacokinetics Adverse effects Contraindications Summary

Why Do CCBs Act Selectively on Cardiac and Vascular Muscle?

N-type and P-type Ca2+ channels mediate neurotransmitter release in neurons Ca2+ Ca2+ Ca2+ Ca2+ Ca2+ postsynaptic cell

Skeletal muscle relies on intracellular Ca2+ for contraction Myofibril Plasma membrane Transverse tubule Terminal cisterna of SR Tubules of Triad T

Cardiac cells rely on L-type Ca2+ channels for contraction and for the upstroke of the AP in slow response cells Contractile Cells (atria, ventricle) L-Type Ca2+ Slow Response Cells (SA node, AV node)

Vascular smooth muscle relies on Ca2+ influx through L-type Ca2+ channels for contraction (graded, Ca2+ dependent contraction) L-Type Ca2+

CCBs Act Selectively on Cardiovascular Tissues Neurons rely on N-and P-type Ca2+ channels Skeletal muscle relies primarily on [Ca]i Cardiac muscle requires Ca2+ influx through L-type Ca2+ channels - contraction (fast response cells) - upstroke of AP (slow response cells) Vascular smooth muscle requires Ca2+ influx through L-type Ca2+ channels for contraction

Outline Introduction Pharmacokinetics CCB binding sites Heterogeneity of action Cardiac & hemodynamic differentiation Pharmacokinetics Adverse effects Contraindications Summary

Non -dihydropyridines: equipotent for cardiac tissue and vasculature Differential effects of different CCBs on CV cells Dihydropyridines: Selective vasodilators Non -dihydropyridines: equipotent for cardiac tissue and vasculature Peripheral vasodilation Heart rate moderating Peripheral and coronary vasodilation SN AV Potential reflex increase in HR, myocardial contractility and O2 demand Coronary VD SN AV Reduced inotropism

Hemodynamic Effects of CCBs Verapamil Diltiazem Nifedipine Peripheral vasodilatation    Coronary vasodilatation    Preload 0/ Afterload    Contractility  0/ / * Heart rate 0/  /0 AV conduction  

Outline Introduction Pharmacokinetics CCB binding sites Heterogeneity of action Cardiac & hemodynamic differentiation Pharmacokinetics Adverse effects Contraindications Summary

CCBs: Pharmacokinetics Agent Oral Absorption (%) Bioavail- Ability (%) Protein Bound (%) Elimination Half-Life (h) Verapamil >90 10-35 83-92 2.8-6.3* Diltiazem >90 41-67 77-80 3.5-7 Nifedipine >90 45-86 92-98 1.9-5.8 Nicardipine -100 35 >95 2-4 Isradipine >90 15-24 >95 8-9 Felodipine -100 20 >99 11-16 Amlodipine >90 64-90 97-99 30-50

Outline Introduction Pharmacokinetics CCB binding sites Heterogeneity of action Cardiac & hemodynamic differentiation Pharmacokinetics Adverse effects Contraindications Summary

Caution w/beta blockers Comparative Adverse Effects   Diltiazem Verapamil Dihydropyridines Overall 0-3% 10-14% 9-39% Hypotension ++ +++ Headaches + Peripheral Edema Constipation CHF (Worsen) AV block Caution w/beta blockers

CCBs - Monitoring heart rate blood pressure anginal symptoms signs of CHF adverse effects

Outline Introduction Pharmacokinetics CCB binding sites Heterogeneity of action Cardiac & hemodynamic differentiation Pharmacokinetics Adverse effects Contraindications Summary

Contradications for CCBs Contraindication Verapamil Nifedipine Diltiazem Hypotension + ++ + Sinus bradycardia + + AV conduction defects ++ ++ Severe cardiac failure ++ + +

Outline Introduction Pharmacokinetics CCB binding sites Heterogeneity of action Cardiac & hemodynamic differentiation Pharmacokinetics Adverse effects Contraindications Summary

Which CCB is most likely to cause hypotension and reflex tachycardia? Diltiazem Nifedipine Verapamil

Contraindications for CCBs include (choose all appropriate): Supraventricular tachycardias Hypotension AV heart block Hypertension Congestive heart failure

CCBs may improve cardiac function by: Reducing cardiac afterload Increasing O2 supply Decreasing cardiac preload Normalizing heart rate in patients with supraventricular tachycardias

Thank you!